Invesco Biotechnology & Genome ETF
PBE
#2014
ETF rank
$0.26 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
$83.57
Share price
2.10%
Change (1 day)
23.86%
Change (1 year)

Invesco Biotechnology & Genome ETF - Holdings

Etf holdings as of February 5, 2026

Number of holdings: 32

Full holdings list

Weight %NameTickerShares Held
5.89%
Gilead Sciences IncGILD103770
5.43%
Amgen IncAMGN38885
5.24%
Illumina IncILMN103203
5.18%
Biogen IncBIIB73517
4.97%
Regeneron Pharmaceuticals IncREGN17072
4.96%
United Therapeutics CorpUTHR27241
4.78%
Incyte CorpINCY122358
3.89%
Amicus Therapeutics IncFOLD716939
3.77%
Alnylam Pharmaceuticals IncALNY29936
3.65%
Dynavax Technologies CorpDVAX619803
2.99%
Royalty Pharma PLCRPRX178379
2.92%
QIAGEN NVQGEN150201.3786
2.89%
MannKind CorpMNKD1382171
2.86%
Ionis Pharmaceuticals IncIONS90302
2.86%
Halozyme Therapeutics IncHALO95817
2.79%
Bio-Techne CorpTECH111680
2.77%
BioMarin Pharmaceutical IncBMRN127758
2.77%
Collegium Pharmaceutical IncCOLL155580
2.74%
Catalyst Pharmaceuticals IncCPRX301597
2.70%
Exelixis IncEXEL167824
2.64%
ACADIA Pharmaceuticals IncACAD296675
2.63%
Neurocrine Biosciences IncNBIX50198
2.48%
Protagonist Therapeutics IncPTGX80859
2.46%
BioCryst Pharmaceuticals IncBCRX1038146
2.45%
Vericel CorpVCEL182370
2.44%
PTC Therapeutics IncPTCT88821
2.34%
TG Therapeutics IncTGTX221373
2.25%
Repligen CorpRGEN42392
2.12%
Madrigal Pharmaceuticals IncMDGL12061
2.01%
Veracyte IncVCYT151832
0.07%
Invesco Government & Agency PortfolioAGPXX189569.5
0.03%
CASH & EQUIVALENTSUSD84861.55